Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV
The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What's New in the Guidelines. The updates to the guidelines are outlined below.
New Chapter Added to the Guidelines (Five Sections)
Cardiovascular and Metabolic Complications in People With HIV
Introduction
Immune Activation and Inflammation Among People With HIV Receiving Antiretroviral Therapy
Cardiovascular Complications in People With HIV
Statin Therapy as Primary Prevention of Atherosclerotic Disease in People With HIV
Weight Gain in People With Treated HIV
Sections With Key Updates
Laboratory Testing for Initial Assessment and Monitoring of People With HIV Receiving Antiretroviral Therapy
Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring
Initiation of Antiretroviral Therapy
Suboptimal CD4 Cell Recovery Despite Viral Suppression (previously Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression)
Cost Considerations and Antiretroviral Therapy
Sections With Minor Updates
Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)
Adverse Effects of Antiretroviral Medications
Appendix A. Drug Characteristics Tables
Appendix B: Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency
Additional information to the following link: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV | NIH